Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients

NCT02066103 is registered in ClinicalTrials.gov with Mercator MedSystems, Inc. as lead sponsor.

NCT NCT02066103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02066103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients
Lead sponsor
Mercator MedSystems, Inc.
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2014
Completion date
June 30, 2016
Enrollment
20 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

malignant airway obstruction secondary to non-small cell lung cancer